Relaxation Program for Breast Cancer
Trial Summary
What is the purpose of this trial?
The goal of this behavioral research study is to compare two different forms of relaxation programs that will include stretching and relaxation techniques, in order to learn if and how well they may help to improve physical and emotional well-being. This will be tested in patients with breast cancer who are receiving radiation therapy. For comparison purposes, there will also be a group of participants that does not take part in the relaxation programs. This is an investigational study. The relaxation programs are being compared for research purposes only. An "assessment" is any time you complete a set of scheduled activities for this study, such as tests and questionnaires. Up to 700 patients will take part in this study. All will be enrolled at MD Anderson.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on relaxation programs, so it's likely you can continue your medications, but please confirm with the study team.
What data supports the effectiveness of the Relaxation Program treatment for breast cancer?
Research shows that relaxation training can help reduce anxiety, depression, and other negative feelings in cancer patients, including those undergoing chemotherapy for breast cancer. It also helps lessen physical side effects like nausea and high blood pressure, improving overall well-being during treatment.12345
Is the Relaxation Program safe for humans?
How does the relaxation program for breast cancer differ from other treatments?
The relaxation program for breast cancer is unique because it focuses on improving mental health and quality of life through techniques like muscle relaxation and stress management, rather than directly targeting the cancer itself. This approach helps patients cope with the psychological demands of cancer, reducing depression, anxiety, and stress, which are common during treatment.268910
Research Team
Lorenzo Cohen
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for women aged 18 or older with stage 0 - III breast cancer, who are about to start daily radiation therapy for 4-6 weeks. Participants must be able to communicate in English or Spanish. It's not open to those who've practiced yoga recently, have significant mobility issues, major psychiatric conditions like schizophrenia or bipolar disorder, or haven't had surgery for their cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy
Participants undergo radiation therapy while participating in relaxation programs or control group activities
Follow-up
Participants are monitored for safety and effectiveness after treatment, including questionnaires and saliva testing
Maintenance Intervention
Participants in the maintenance intervention arm receive telephone counseling and booster sessions post-radiotherapy
Treatment Details
Interventions
- Relaxation Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator